Page 46 - நோர்வே நிறுவனம் ஆஃப் பொது ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A Broader Basis for Making Decisions concerning Viral Vector Vaccines The final decision concerning the use of the AstraZeneca and Janssen COVID-19 vaccines will be taken by the Norwegian Government. A committee of experts, both foreign and national, will be appointed to examine the consequences of using or not using these vaccines in the vaccination programme. The Norwegian Institute of Public Health recommends removing the AstraZeneca vaccine from the vaccination programme permanently due to the risk of rare but severe side effects. The Norwegian Institute of Public Health has assessed this in relation to the COVID-19 situation in Norway. The assessment made by the experts at the Norwegian Institute of Public Health is solid and thorough. Working with colleagues in Denmark, the Norwegian Institute of Public Health and the community of experts in Norway were quick to discover these side effects and assess the causal connection to the vaccine.

Kathrine kristoffersenAnne kjersti befringJohn edmundsLars vorlandGunnar bovimJon michael granIngrid hjortSteinar krokstadMarie paule kienyUniversity hospital of north norwayNorwegian institute of public healthNorwegian business schoolSpecialist health serviceLike the norwegian institute of public healthCare services bentNorway regional health authority